PMA device
Hintermann Series H3 Total Ankle Replacement System
Dt Medtech, LLC · Prosthesis, Ankle, Uncemented, Non-Constrained (NTG, Class III) · First FDA decision Jun 4, 2019, newest Jul 31, 2026Foot and ankle conditions
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
2
Naming "Hintermann Series H3"
MAUDE reports
20
Brand "Hintermann Series H3", since 2015
PubMed studies
0
Mentioning "Hintermann Series H3"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Hintermann Series H3 Total Ankle Replacement System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Hintermann Series H3 Total Ankle Replacement SystemPMA supplement
P160036-S008 · Decided Jul 31, 2026 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, ankle, uncemented, non-constrained (NTG) · Orthopedic Surgery
- Hintermann Series H3 Total Ankle Replacement SystemPMA supplement
P160036-S005 · Decided Sep 20, 2024 · 367 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, ankle, uncemented, non-constrained (NTG) · Orthopedic Surgery
- Hintermann Series H3 Total Ankle Replacement SystemPMA supplement
P160036-S004 · Decided Nov 6, 2023 · 182 days after receipt · Normal 180 Day Track
Device type: Prosthesis, ankle, uncemented, non-constrained (NTG) · Orthopedic Surgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Hintermann Series H3", any status and sponsor, newest update first.
- Post Approval Study2: Hintermann Series H3 Total Ankle Replacement SystemActive, not recruiting
DT MedTech, LLCNot on our public-company list
NCT04770870 · 94 participants (planned) · Start Feb 1, 2022 · Primary completion Sep 1, 2029
Device: Hintermann Series H3 Total Ankle Replacement System · For: Osteoarthritis Ankle; Post-Traumatic Osteoarthritis of Ankle; Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)
Sites: Little Rock, Arkansas; Mission Hills, California; Sarasota, Florida · 11 sites in all
- Post- Approval Hintermann Series H® Study 1Status unknown
DT MedTech, LLCNot on our public-company list
NCT06514196 · 298 participants (planned) · Start Jun 18, 2020 · Primary completion Nov 30, 2024
Device: Hintermann Series H3 Total Ankle Replacement System · For: Ankle Osteoarthritis; Post-Traumatic Osteoarthritis of Ankle; Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)
Sites: Bruderholz, Switzerland
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Hintermann Series H3", and for the whole product code for context.
This brand
20 reports: 2 malfunction, 18 injury, 0 death
Whole product code NTG
1,522 reports: 92 malfunction, 1,411 injury, 18 death
Newest reports for this brand
- Hintermann Series H3Injury
3012104767-2026-00009 · Received Oct 16, 2026 · Event dated Sep 23, 2026
Device type: Prosthesis, Ankle, Uncemented, Non-Constrained (NTG)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Insufficient Information
- Hintermann Series H3Injury
3012104767-2026-00008 · Received Oct 6, 2026 · Event dated Sep 25, 2026
Device type: Prosthesis, Ankle, Uncemented, Non-Constrained (NTG)
Device problem as coded: Fracture
Patient problem as coded: Insufficient Information
3012104767-2026-00007 · Received Oct 5, 2026 · Event dated Aug 13, 2026
Device type: Prosthesis, Ankle, Uncemented, Non-Constrained (NTG)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Bacterial Infection; Medical device site infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Hintermann Series Talar Implant, Left, Size 2 REF 302112Open, Classified
Z-2399-2026 · Started Mar 24, 2026 · Posted by FDA Jun 10, 2026
Reason given: Through customer complaints, the ankle replacement system was found to contain incorrect devices: Left implant packaging and labeling bears a right implant device.
Cause as FDA categorized it: Labeling Change Control · Device type: Prosthesis, Ankle, Uncemented, Non-Constrained (NTG)
Published research
The most relevant PubMed records for "Hintermann Series H3"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NTG.
- Scandinavian Total Ankle Replacement (STAR)Djo Global · PMA 2024
- STAR PSI SystemDjo Global · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.